相似文献
1
Fluoroquinolone resistance in Ureaplasma parvum in the United States.
J Clin Microbiol. 2006 Apr;44(4):1590-1. doi: 10.1128/JCM.44.4.1590-1591.2006.
2
Comparison of full gyrA, gyrB, parC and parE gene sequences between all Ureaplasma parvum and Ureaplasma urealyticum serovars to separate true fluoroquinolone antibiotic resistance mutations from non-resistance polymorphism.
J Antimicrob Chemother. 2009 Sep;64(3):529-38. doi: 10.1093/jac/dkp218. Epub 2009 Jun 30.
3
Analysis of mutations in DNA gyrase and topoisomerase IV of Ureaplasma urealyticum and Ureaplasma parvum serovars resistant to fluoroquinolones.
Infect Genet Evol. 2017 Jan;47:64-67. doi: 10.1016/j.meegid.2016.11.019. Epub 2016 Nov 21.
4
Fluoroquinolone resistance and gyrA and parC mutations of Escherichia coli isolated from chicken.
J Microbiol. 2005 Oct;43(5):391-7.
5
[Fluoroquinolone resistance mutations in topoisomerase genes of Salmonella typhimurium isolates].
Wei Sheng Yan Jiu. 2004 Sep;33(5):591-4.
6
DNA gyrase and topoisomerase IV mutations in clinical isolates of Ureaplasma spp. and Mycoplasma hominis resistant to fluoroquinolones.
Antimicrob Agents Chemother. 2003 Oct;47(10):3323-5. doi: 10.1128/AAC.47.10.3323-3325.2003.
7
Rapid detection of gyrA and parC mutations in fluoroquinolone-resistant Neisseria gonorrhoeae by denaturing high-performance liquid chromatography.
J Microbiol Methods. 2004 Dec;59(3):415-21. doi: 10.1016/j.mimet.2004.08.004.
8
Analysis of the quinolone-resistance determining region of the gyrA gene and the analogous region of the parC gene in Ureaplasma parvum and Ureaplasma urealyticum detected in first-void urine of men with non-gonococcal urethritis.
J Antimicrob Chemother. 2013 Feb;68(2):480-2. doi: 10.1093/jac/dks417. Epub 2012 Oct 22.
9
Frequent topoisomerase IV mutations associated with fluoroquinolone resistance in Ureaplasma species.
J Med Microbiol. 2015 Nov;64(11):1315-1320. doi: 10.1099/jmm.0.000153. Epub 2015 Aug 4.
10
The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
J Antimicrob Chemother. 2006 Oct;58(4):733-40. doi: 10.1093/jac/dkl333. Epub 2006 Aug 8.
引用本文的文献
1
Vaginal Cuff Infection Caused by After Hysterectomy for Uterine Cervical Cancer: A Case Report.
Case Rep Infect Dis. 2024 Oct 21;2024:4114954. doi: 10.1155/2024/4114954. eCollection 2024.
2
Septic Arthritis, a Clinic Challenge.
Diagnostics (Basel). 2022 Oct 6;12(10):2416. doi: 10.3390/diagnostics12102416.
3
Infection Prevalence and Antibiotic Resistance Levels in and in Gynecological Outpatients of a Tertiary Hospital in China from 2015 to 2018.
Can J Infect Dis Med Microbiol. 2021 Jan 13;2021:8842267. doi: 10.1155/2021/8842267. eCollection 2021.
4
Antimicrobial Susceptibility and Clonality of Clinical Ureaplasma Isolates in the United States.
Antimicrob Agents Chemother. 2016 Jul 22;60(8):4793-8. doi: 10.1128/AAC.00671-16. Print 2016 Aug.
5
Antibiotic Resistance among Clinical Ureaplasma Isolates Recovered from Neonates in England and Wales between 2007 and 2013.
Antimicrob Agents Chemother. 2015 Oct 12;60(1):52-6. doi: 10.1128/AAC.00889-15. Print 2016 Jan.
6
In vitro antibacterial activity of AZD0914 against human Mycoplasmas and Ureaplasmas.
Antimicrob Agents Chemother. 2015;59(6):3627-9. doi: 10.1128/AAC.04945-14. Epub 2015 Mar 30.
7
In vitro activity of five quinolones and analysis of the quinolone resistance-determining regions of gyrA, gyrB, parC, and parE in Ureaplasma parvum and Ureaplasma urealyticum clinical isolates from perinatal patients in Japan.
Antimicrob Agents Chemother. 2015 Apr;59(4):2358-64. doi: 10.1128/AAC.04262-14. Epub 2015 Feb 2.
8
Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum in asymptomatic women in Northern Greece.
Hippokratia. 2013 Oct;17(4):319-21.
9
Antibiotic susceptibility profiles of Mycoplasma hominis and ureaplasma urealyticum isolated during a population-based study concerning women infertility in northeast romania.
Braz J Microbiol. 2011 Jan;42(1):256-60. doi: 10.1590/S1517-83822011000100032.
10
Chromosomal mutations responsible for fluoroquinolone resistance in Ureaplasma species in the United States.
Antimicrob Agents Chemother. 2012 May;56(5):2780-3. doi: 10.1128/AAC.06342-11. Epub 2012 Feb 27.
本文引用的文献
1
Mycoplasmas and ureaplasmas as neonatal pathogens.
Clin Microbiol Rev. 2005 Oct;18(4):757-89. doi: 10.1128/CMR.18.4.757-789.2005.
2
Characterization of ureaplasmas isolated from preterm infants with and without bronchopulmonary dysplasia.
J Clin Microbiol. 2005 Sep;43(9):4852-4. doi: 10.1128/JCM.43.9.4852-4854.2005.
3
DNA gyrase and topoisomerase IV mutations in clinical isolates of Ureaplasma spp. and Mycoplasma hominis resistant to fluoroquinolones.
Antimicrob Agents Chemother. 2003 Oct;47(10):3323-5. doi: 10.1128/AAC.47.10.3323-3325.2003.
4
Study of isolation of fluoroquinolone-resistant Ureaplasma urealyticum and identification of mutant sites.
Chin Med J (Engl). 2002 Oct;115(10):1573-5.
5
Peptide methionine sulfoxide reductase (MsrA) is a virulence determinant in Mycoplasma genitalium.
J Bacteriol. 2001 Oct;183(19):5645-50. doi: 10.1128/JB.183.19.5645-5650.2001.
6
The complete sequence of the mucosal pathogen Ureaplasma urealyticum.
Nature. 2000 Oct 12;407(6805):757-62. doi: 10.1038/35037619.
7
In vitro activity of trovafloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterized.
Antimicrob Agents Chemother. 2000 Sep;44(9):2557-60. doi: 10.1128/AAC.44.9.2557-2560.2000.
8
Association of chronic urinary symptoms in women and Ureaplasma urealyticum.
Urology. 2000 Apr;55(4):486-9. doi: 10.1016/s0090-4295(99)00555-5.
9
Disruption of gene mg218 of Mycoplasma genitalium through homologous recombination leads to an adherence-deficient phenotype.
Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):5227-32. doi: 10.1073/pnas.96.9.5227.
10
DNA gyrase, topoisomerase IV, and the 4-quinolones.
Microbiol Mol Biol Rev. 1997 Sep;61(3):377-92. doi: 10.1128/mmbr.61.3.377-392.1997.
Zotero 插件